cardiovascular benefits of glp-1 drugs like semaglutide and tirzepatide have surged in popularity for diabetes and weight loss — now used by about 1 in 8 U.S. adults and known to protect the heart. ⁠ ⁠ Study finds heart benefits of

GHK-Cus anti-inflammatory effect does not translate into measurable fat loss in our patient population

[1] These medications work by mimicking the action of naturally occurring GLP-1, an incretin hormone that stimulates insulin secretion in response to food intake, suppresses glucagon release, slows gastric emptying, and promotes satiety through central nervous system pathways

The Nrf2 pathway is typically induced in response to oxidative stress, inflammation, and other cellular stressors [77]

Initially created to manage type 2 diabetes, it has also proven effective in aiding weight loss for adults struggling with overweight people or those who are obese and managing at least one related health condition

Nevertheless, data generated from multiple groups have demonstrated the presence of senescent cells in postmortem human brain (Figure 1)

10.1016/j.jdermsci.2020.03.001 180